A new study, led by investigators in the Department of Physical Medicine & Rehabilitation at the UNC School of Medicine, reveals how dietary changes significantly reduce persistent post-traumatic headaches, a common and debilitating consequence of traumatic brain injury.

The parents of twins Amelia and Makenzie Kahn, who have been battling Batten disease, a rare genetic disorder, for eight years, are now celebrating signs of progress one year into a first-in-kind clinical study at UNC Health. Led by Yael Shiloh-Malawsky, MD, the new personalized treatment, Zebronkysen, is helping to better manage the disease.

UNC Health has named Margaret Ann Bollmeier as the new president of the UNC Health Foundation and Chief Philanthropy Officer for UNC Health and the UNC School of Medicine.

Published in Blood, a new study led by UNC School of Medicine’s Alisa Wolberg, PhD, reveals that reducing or blocking the protein that causes blood clot breakdown does not increase the formation of dangerous clots known as thromboses.

Led by UNC School of Medicine’s Weili Lin, PhD, researchers document cognitive milestones revealed in children from birth to toddlerhood in brain imaging study.

Study reveals hypercortisolism identified in 24 percent of patients with difficult-to-control type 2 diabetes. John Buse, MD, PhD, director of UNC’s Diabetes Care Center, is lead author.

From advancing community care, pursuing competitive specialties, to becoming a first-generation student, these are the stories of four medical students as they persevered to Match Day 2025.

An evaluation led by UNC’s Seth A. Berkowitz, MD, MPH, was published in the Journal of the American Medical Association.

Wesley Burks, MD, CEO of UNC Health and dean of the UNC School of Medicine, professor of pediatrics, Division of Pediatric Allergy/Immunology, Department of Pediatrics and Corinne A. Keet, MD, PhD, professor of pediatrics, Division of Pediatric Allergy/Immunology, Department of Pediatrics, write editorial in New England Journal of Medicine Evidence titled, “To Eat or Not to Eat: Oral Immunotherapy for High Threshold Peanut Allergy.”

Co-led by UNC School of Medicine’s David Y. Hwang, MD, newly released updated guidelines from the Society of Critical Care Medicine (SCCM) reveal how family centered care for adult ICUs is paramount and an invaluable approach.

Randomized, placebo-controlled trial finds that low-dose semaglutide reduces amount of alcohol consumption, alcohol cravings, and heavy drinking days. Reductions in cigarettes per day were also seen.

Drug work one of “7 Medical Breakthroughs that Changed Medicine in 2024.”

Tag: UNC School of Medicine

New Research Finds Changing Your Diet Could Ease Persistent Headaches After Brain Injury

Family Experiences Unexpected Improvements of Personalized Treatment for Batten Disease

UNC Health Names Margaret Ann Bollmeier Chief Philanthropy Officer

UNC Study Offers New Hope for Safer Bleeding Treatments

Study Reveals Key Roles in Developmental Milestones of the Brain in Children

Research Shows Prevalence of Hypercortisolism in Difficult-to-Control Type 2 Diabetes

The Road to Match Day. Four Medical Students Share Their Journeys.

NC Healthy Opportunities Program Helped Reduce Medicaid Costs

Burks and Keet Publish Editorial on Oral Immunotherapy for High Threshold Peanut Allergy

A Fresh Approach to Family-Centered Care for Adult ICUs

Semaglutide Shows Promise in Reducing Cravings for Alcohol, Heavy Drinking

UNC ‘Breakthrough’ Research on Food Allergy Drug Featured in National Geographic